Ladenburg Thalmann Financial Services’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
Other funds holding PTLA
JSP
CCM
NAM
Ladenburg Thalmann Financial Services's PTLA Position: Q4 2019 in Review
Ladenburg Thalmann Financial Services reduced its Portola Pharmaceuticals, Inc. (PTLA) stake by 2.3% in Q4 2019, selling an estimated $7.45K and leaving 11,498 shares worth $275K. The position accounts for ﹤0.01% of the portfolio, ranked #2268.
Ladenburg Thalmann Financial Services first reported a position in PTLA in Q4 2014 and has held it in 21 quarters since. The position peaked at $403K in Q2 2019. 224 funds tracked by Wall St. Rank hold PTLA as of Q4 2019.
- Ladenburg Thalmann Financial Services held 11,498 shares of Portola Pharmaceuticals, Inc. worth $275K as of Q4 2019.
- Ladenburg Thalmann Financial Services sold 270 Portola Pharmaceuticals, Inc. shares in Q4 2019, an estimated $7.45K.
- Portola Pharmaceuticals, Inc. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2268 holding.
- Ladenburg Thalmann Financial Services first reported a position in Portola Pharmaceuticals, Inc. in Q4 2014 and has held it in 21 quarters since.
- Ladenburg Thalmann Financial Services's Portola Pharmaceuticals, Inc. position peaked at $403K in Q2 2019.
- 224 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.